BGI Genomics
Hongyan An is an experienced sales executive in the biotechnology field, currently serving in that role at Sequencing and Mass Spectrometry services since January 2024. Hongyan has held the position of Regional Sales Manager at BGI Genomics since October 2021, providing comprehensive support to customers throughout next-generation sequencing (NGS) and mass spectrometry projects. Prior to these roles, Hongyan served as the Director of Sale/Business Unit Head at Yinfeng Biologics USA Corporation, and as General Manager at Novogene America from September 2015 to October 2017. Hongyan's career in BGI Genomics also includes a directorial role from May 2013 to May 2015. Holding a Doctor of Philosophy (Ph.D.) degree in Veterinary Microbiology and Immunobiology from Université de Montréal, Hongyan combines academic expertise with extensive industry experience.
This person is not in any offices
BGI Genomics
3 followers
BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a global network of collaborators. BGI Genomics is the world’s leading provider of genomic and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care. To provide these services, we operate a large network of service Laboratories in China, Hong Kong, the US and Europe. Our customers benefit from the highest level of sequencing experience in the world to support their research and drug discovery projects. Our service laboratories operate under strict internationally recognized quality systems, such as those from CAP and ISO. More recently, BGI developed and launched its own DNBseq™ sequencing technology, based on DNA Nanoball sequencing technology that was invented in our Complete Genomics research facility in Silicon Valley, California. Scientists around the world now rely on DNBseq NGS services for the highest quality data at the lowest cost.